Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$5.86 - $9.43 $886,618 - $1.43 Million
151,300 New
151,300 $1.39 Million
Q4 2021

Feb 11, 2022

SELL
$5.47 - $7.13 $902,550 - $1.18 Million
-165,000 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$5.28 - $6.29 $422,400 - $503,200
80,000 Added 94.12%
165,000 $942,000
Q1 2021

May 17, 2021

BUY
$5.79 - $8.85 $492,150 - $752,250
85,000 New
85,000 $493,000

Others Institutions Holding MIST

About Milestone Pharmaceuticals Inc.


  • Ticker MIST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,010,900
  • Market Cap $55.8M
  • Description
  • Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...
More about MIST
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.